Virological breakthrough and resistance in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice

Hepatology

Volumn 54, Issue 3, 2011, Pages 1104-1105

  Ridruejo, Ezequiel ^a,c   Adrover, Raúl ^b   Silva, Marcelo O ^c  

^a CEMIC   (Argentina)

^b Hepatology Unit Centro de Hepatología La Plata Provincia de Buenos Aires   (Argentina)

^c UNIVERSIDAD AUSTRAL   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ENTECAVIR;

ANTIVIRAL RESISTANCE; CHRONIC DISEASE; CHRONIC HEPATITIS B; HEPATITIS B; HUMAN; INCIDENCE; LETTER; PATIENT COMPLIANCE; PATIENT COUNSELING; PHASE 3 CLINICAL TRIAL (TOPIC); PHYSICAL SENSITIVITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT DURATION; TREATMENT OUTCOME; VIROLOGICAL BREAKTHROUGH;

EID: 80052065782     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.24498     Document Type: Letter

References (7)

1. Hongthanakorn C, Chotiyaputta W, Oberhelman K, Fontana RJ, Marrero JA, Licari T, Lok AS. Virological breakthrough and resistance in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice. HEPATOLOGY 2011; 53: 1854-1863.
2. Ridruejo E, Adrover R, Cocozzella D, Reggiardo MV, Mendizábal M, Estepo C, et al. Effectiveness of entecavir in chronic hepatitis B NUC naive patients in routine clinical practice. Int J Clin Pract. In press.
3. P. Lampertico, M. Viganò, F. Facchetti, E. Minola, O. Fracassetti, F. Suter, et al. Effectiveness of entecavir for NUC-naive, HBeAg-negative chronic hepatitis B patients in clinical practice: a 2-year multicenter cohort study in 311 patients. J Hepatol 2010; 52(Suppl. 1): S389.
4. Lampertico P, Viganò M, Soffredini R, Facchetti F, Minola E, Suter F, et al. Maintained long-term suppression of HBV replication in NUC-naïve patients with chronic hepatitis B treated with ETV monotherapy in field practice: the Italian multicenter experience. HEPATOLOGY 2010; 52(Suppl. 1): S514A.
5. Lim SG, 2, Aung MO, Sutedja D, Lee YM, Lee GH, Fernandes ML, et al. Outcomes of treatment for chronic hepatitis B with entecavir therapy. HEPATOLOGY 2010; 52(Suppl. 1): S537A.
6. Lai CL, Shouval D, Lok AS, Chang TT, Cheinquer H, Goodman Z, et al. Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B. N Engl J Med 2006; 354: 1011-1020.
7. Chang TT, Gish RG, de Man R, Gadano A, Sollano J, Chao YC, et al. A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B. N Engl J Med. 2006; 354: 1001-1010.